Clinical efficacy of new JAK inhibitors under development. Just more of the same?
Author:
Affiliation:
1. Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, Division of Rheumatology, University Hospitals Leuven, Leuven, Belgium
Funder
Roche
BMS
Janssen
Gilead Sciences, Inc.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
http://academic.oup.com/rheumatology/article-pdf/58/Supplement_1/i27/27984865/key256.pdf
Reference41 articles.
1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017
2. A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis;Meyfroidt;Clin Rheumatol,2015
3. Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice;Leon;Scand J Rheumatol,2016
4. Twelve-year retention rate of first-line tumor necrosis factor inhibitors in rheumatoid arthritis: real-life data from a local registry;Favalli;Arthritis Care Res (Hoboken),2016
5. Costs of drugs for treatment of rheumatic diseases;Westhovens;RMD Open,2016
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09
2. Revisiting Structure-activity Relationships: Unleashing the potential of selective Janus kinase 1 inhibitors;Bioorganic Chemistry;2024-08
3. The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis;PLOS ONE;2024-06-21
4. VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling;World Journal of Stem Cells;2024-02-26
5. Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease;Medicina;2024-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3